Review requirement under section 26A of the Narcotic Drugs Act assessing the operation of the 2016 amendments after two years.
This discussion paper supported the independent review of the Narcotic Drugs Act 1967, which examined how the Act was operating following the 2016 amendments that introduced Australia's medicinal cannabis framework.
The 2016 amendments to the Act included a requirement for the Australian Government to review the operation of the legislation after the second anniversary of the amendments. This discussion paper formed part of the consultation process for that review.
The review considered whether the Act was achieving its objectives and whether changes were needed to improve the regulation of medicinal cannabis cultivation, production and manufacture in Australia.
The discussion paper explores:
